Bristol-Myers Squibb Company (NYSE:BMY) Position Raised by Jennison Associates LLC

Lloyd Doyle
November 18, 2017

Umb Bank N A sold 171,942 shares as the company's stock declined 1.04% while stock markets rallied. The Amg National Trust Bank holds 9,454 shares with $1.78 million value, down from 11,454 last quarter. Sandell Asset Management Corp who had been investing in Bob Evans Farms Inc (Call) for a number of months, seems to be less bullish one the $1.55B market cap company. Sei Investments stated it has 5,872 shares or 0% of all its holdings. About 1.58M shares traded. Bob Evans Farms Inc (NASDAQ:BOBE) has risen 55.35% since November 17, 2016 and is uptrending. It has outperformed by 0.16% the S&P500.

Mckinley Capital Management Inc increased Enzo Biochem Inc (ENZ) stake by 39.8% reported in 2017Q2 SEC filing. Geneva Advsrs Ltd holds 1.33% of its portfolio in Merck & Co., Inc. After $0.75 actual earnings per share reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts -10.67% negative EPS growth. The company has a market capitalization of $101,260.00, a PE ratio of 20.63, a price-to-earnings-growth ratio of 2.41 and a beta of 1.18. The fund owned 111,651 shares of the biopharmaceutical company's stock after selling 2,656 shares during the quarter.

Bristol-Myers Squibb (NYSE:BMY) last announced its quarterly earnings data on Thursday, October 26th. It has underperformed by 39.89% the S&P500. Cowen and Company restated a "hold" rating and set a $65.00 target price on shares of Bristol-Myers Squibb in a research report on Tuesday, September 19th.

October 27 investment analysts at Piper Jaffray Companies held the stock rating at "Hold" targeting a price of $60.00. Bristol-Myers Squibb presently has an average rating of "Hold" and a consensus target price of $64.93. On Monday, November 13 the stock rating was maintained by BMO Capital Markets with "Sell". The firm earned "Buy" rating on Tuesday, September 29 by UBS. Credit Suisse Group restated a "hold" rating and set a $61.00 target price (up from $58.00) on shares of Bristol-Myers Squibb in a research report on Friday, October 27th. The company now has a consensus rating of "Hold" and a consensus price target of $64.93. Stockholders of record on Friday, October 6th were paid a $0.39 dividend. On October 26, 2017 BMO Capital Markets updated guidance on BMY with a rating of "Sell" and a price target of $49.00.

More notable recent Bristol-Myers Squibb Co (NYSE:BMY) news were published by: Barrons.com which released: "Which Will Pfizer Buy?"

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. BMY's SI was 7.44M shares in November as released by FINRA. The ex-dividend date was Thursday, October 5th.

Investors sentiment decreased to 0.95 in 2017 Q2. Its up 0.06, from 1.02 in 2017Q1.


Several equities research analysts have commented on the stock. 120 funds opened positions while 451 raised stakes. Mai Capital Mgmt holds 131,692 shares. Aspiriant Limited Company invested 0.08% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Wealthtrust Fairport Ltd Liability has 0.04% invested in Bristol-Myers Squibb Co (NYSE:BMY). Bb&T owns 272,403 shares. Murphy Cap Incorporated invested 0.66% in Bristol-Myers Squibb Co (NYSE:BMY). Olstein Capital Management L P reported 263,000 shares. Bristol-Myers Squibb had a net margin of 20.56% and a return on equity of 32.41%. Tradewinds Capital Management LLC grew its stake in shares of Bristol-Myers Squibb by 34.6% in the 2nd quarter. Tirschwell & Loewy reported 9,900 shares stake. The SI to Solitario Exploration & Royalty Corporation's float is 0.13%. Associated Banc holds 0.48% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 150,842 shares. Walleye Trading Limited has 87,264 shares.

Sandell Asset Management Corp, which manages about $998.58 million and $402.89 million US Long portfolio, upped its stake in Spdr S&P 500 Etf Tr (Put) (SPY) by 25,000 shares to 125,000 shares, valued at $30.23 million in 2017Q2, according to the filing. The stock saw a fall in short interest from October 13, 2017 to October 31, 2017 of -21.19%.

Investors sentiment increased to 1.07 in Q2 2017. TRUE Private Wealth Advisors increased its holdings in shares of Bristol-Myers Squibb by 6.1% in the 2nd quarter. 67 funds opened positions while 232 raised stakes. Wills Fincl accumulated 0.19% or 4,574 shares. 1,438 are held by City Holdings Com. Enzo Biochem Inc now has $423.59 million valuation. Bbva Compass Bancshares has invested 0.15% in Goldman Sachs Group Inc (NYSE:GS). The Michigan-based Ls Advsr Limited Com has invested 0% in Bob Evans Farms Inc (NASDAQ:BOBE).

Bokf decreased Microchip Technology Inc (NASDAQ:MCHP) stake by 87,369 shares to 38,067 valued at $2.94 million in 2017Q2. Argent holds 0.33% or 5,384 shares. 887.72 million shares or 0.62% less from 893.23 million shares in 2017Q1 were reported. Guggenheim Cap Limited Liability stated it has 3,983 shares or 0% of all its holdings. Bp Plc holds 113,000 shares or 0.14% of its portfolio. 186,372 are owned by Schwab Charles Inc. Hsbc Public Ltd Liability Co invested in 0% or 3,548 shares. Strs Ohio owns 380,003 shares.

Ratings analysis reveals 0 of Northwest Bancshares's analysts are positive. Therefore 50% are positive. Bristol-Myers Squibb Company has a 52-week low of $46.01 and a 52-week high of $66.10. On Friday, September 22 the stock rating was downgraded by William Blair to "Hold". The company was maintained on Friday, July 21 by Bank of America. The Firm connects buyers and sellers around the world. The stock has "Outperform" rating by Robert W. Baird on Wednesday, April 26. The First Allied Advisory Services Inc holds 74,138 shares with $4.14 million value, up from 68,170 last quarter.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER